Talon Therapeutics, Inc.
DelistedCIK 1140028fmd_1DE0RZ36RJ9P1D1M0TXFST3XJ3Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2010 to Mar 31, 2013, 12 periods
| Line item | FY2010 | FY2011 | FY2012 |
|---|---|---|---|
| Realized investment gains (losses) | – | (0) | – |
| Research and development | 20 | 13 | 13 |
| Total operating expenses | 26 | 19 | 21 |
| Operating income | (26) | (19) | (21) |
| Interest expense | 4 | 4 | 4 |
| Interest and investment income | 0 | 0 | 0 |
| Other non-operating income (expense) | – | (0) | – |
| Net income | (26) | (19) | (44) |
| Net income to common shareholders | (58) | (23) | (65) |